- Home
- CEV vs ECOR Comparison
CEV vs ECOR Comparison
Compare CEV & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEV
- ECOR
- Stock Information
- Founded
- CEV 1999
- ECOR 2005
- Country
- CEV United States
- ECOR United States
- Employees
- CEV N/A
- ECOR N/A
- Industry
- CEV Finance/Investors Services
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CEV Finance
- ECOR Health Care
- Exchange
- CEV Nasdaq
- ECOR Nasdaq
- Market Cap
- CEV 75.9M
- ECOR 65.0M
- IPO Year
- CEV N/A
- ECOR 2018
- Fundamental
- Price
- CEV $10.07
- ECOR $14.89
- Analyst Decision
- CEV
- ECOR Strong Buy
- Analyst Count
- CEV 0
- ECOR 1
- Target Price
- CEV N/A
- ECOR $25.00
- AVG Volume (30 Days)
- CEV 19.6K
- ECOR 138.3K
- Earning Date
- CEV 01-01-0001
- ECOR 11-13-2024
- Dividend Yield
- CEV 4.23%
- ECOR N/A
- EPS Growth
- CEV N/A
- ECOR N/A
- EPS
- CEV 0.36
- ECOR N/A
- Revenue
- CEV N/A
- ECOR $23,327,000.00
- Revenue This Year
- CEV N/A
- ECOR $61.40
- Revenue Next Year
- CEV N/A
- ECOR $38.43
- P/E Ratio
- CEV $29.36
- ECOR N/A
- Revenue Growth
- CEV N/A
- ECOR 74.10
- 52 Week Low
- CEV $8.83
- ECOR $5.25
- 52 Week High
- CEV $10.91
- ECOR $17.84
- Technical
- Relative Strength Index (RSI)
- CEV 25.32
- ECOR 59.13
- Support Level
- CEV $10.40
- ECOR $14.11
- Resistance Level
- CEV $10.75
- ECOR $17.84
- Average True Range (ATR)
- CEV 0.09
- ECOR 1.47
- MACD
- CEV -0.06
- ECOR 0.16
- Stochastic Oscillator
- CEV 0.00
- ECOR 47.76
About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest
Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.